Companies are telling their investors how President Donald Trump’s plan to radically remake the U.S. government poses new ...

"We did not meet our financial goals in 2024, and that's reflected in our corporate bonus," a company representative told ...

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound follows a tough 2024, when its shares dropped over 40% due to missed earnings ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Valentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.